Sheldon Sloan

Chief Medical Officer

Sheldon Sloan (Chief Medical Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Spyre Therapeutics, Inc. (SYRE). The largest single filing was $5.6M of SYRE (77,933 sh across 6 lots, as filed), executed May 1.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$7.3M

shares × price, as filed

Last traded

Jul 1

Filed Jul 2

Median ADV $134.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $7.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

SYRE

Spyre Therapeutics, Inc. SYRE · 0 buys · 4 sells 4 filings

Recent filings

SYRESALE Spyre Therapeutics, Inc. View filing → $731K
8,334 sh across 2 lots
Exec Jul 1
Filed Jul 2 · 9:33 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $625K
8,333 sh × $75.00
Exec Jun 3
Filed Jun 3 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $5.6M
77,933 sh across 6 lots
Exec May 1
Filed May 1 · 5:30 PM ET SYRESALE Spyre Therapeutics, Inc. View filing → $398K
7,958 sh × $50.00
Exec Apr 1
Filed Apr 3 · 5:30 PM ET